Robust IMPT and follow-up toxicity in skull base chordoma and chondrosarcoma—a single-institution clinical experience
Robustly optimized IMPT is clinically feasible as a postoperative treatment for skull base chordoma and chondrosarcoma patients. We observed acceptable early toxicities (grade 1-3) that disappeared within the first 3 months after irradiation.
Authors
- Michiel Kroesen (ORCID: https://orcid.org/0000-0002-1346-2277)
- Wouter R. van Furth (ORCID: https://orcid.org/0000-0001-5208-921X)
- Berit M. Verbist (ORCID: https://orcid.org/0000-0002-1010-2583)
- Vesna Miladinovic (ORCID: https://orcid.org/0000-0002-1849-1624)
- Steven Habraken (ORCID: https://orcid.org/0000-0001-9986-886X)
- Augustinus D. G. Krol (ORCID: https://orcid.org/0000-0002-3257-3634)
- Ida E.M. Coremans
- Yvonne L.B. Klaver
Institutions
- Leiden University Medical Center (NL)
- Erasmus MC Cancer Institute (NL)
- VSL National Metrology Institute (NL)
Publication Details
- Journal
- Strahlentherapie und Onkologie
- Published
- 2024-08-29
- DOI
- https://doi.org/10.1007/s00066-024-02280-0
- Citations
- 2
- Primary Topic
- Bone Tumor Diagnosis and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.94
Funders
- Varian Medical Systems
- Siemens Healthineers